1 Product identity

HemoFlo

Other Combinations Capsule 13 ingredients DSLD #18966
Net contents: 60 Veggie Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-11-25
2 Ingredients (13)
IngredientGroupSafety
Vitamin B3NiacinConditionally Safe
Vitamin B6Vitamin B6
Vitamin B12Vitamin B12
Vitamin CVitamin CGenerally Safe
Advanced Viscosity Flow BlendBlend
Salix Alba (White Willow Bark) S.E.White WillowConditionally Safe
Viburnum opulusCramp Bark
Zingiber officinaleGinger
NSK-SD(R) Bacillus subtillus nattoNattokinaseConditionally Safe
Trans-resveratrolResveratrolConditionally Safe
Vegetarian CelluloseCellulose
Rice FlourRice
Magnesium StearateMagnesium stearateGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
White Willow Bark — Conditionally Safe
⚠ Contains salicin (aspirin-like)
⚠ GI irritation
Nattokinase — Conditionally Safe
⚠ Anticoagulant/fibrinolytic effect
⚠ Increased bleeding risk
Resveratrol — Conditionally Safe
⚠ Estrogenic activity
⚠ CYP enzyme inhibition
Magnesium — Generally Safe
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID18966
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-11-25
6 More from Actionetix
View Actionetix Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. HemoFlo — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/products/hemoflo-18966/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG